Abstract
Glycogen synthase kinase 3β (GSK-3β) is implicated in diverse cellular processes such as cell signaling and survival. Accumulating lines of evidence indicate that increased GSK-3β activity contributes to neuronal death and pathogenesis of ischemic stroke. Considering predominant roles of GSK-3β in neuronal apoptosis, modulation of this protein kinase is a reliable strategy for ischemic neuroprotection. In this review, we survey and synthesize the current knowledge about the role of GSK-3β in neuroprotection following the ischemic stroke.
Keywords: Apoptosis, brain, GSK-3β, hypoxia, ischemic stroke, neuronal death.
Current Neurovascular Research
Title:Glycogen Synthase Kinase-β3 in Ischemic Neuronal Death
Volume: 11 Issue: 3
Author(s): Pradeep Hanumanthappa, Asha Densi and Rajanikant Golgodu Krishnamurthy
Affiliation:
Keywords: Apoptosis, brain, GSK-3β, hypoxia, ischemic stroke, neuronal death.
Abstract: Glycogen synthase kinase 3β (GSK-3β) is implicated in diverse cellular processes such as cell signaling and survival. Accumulating lines of evidence indicate that increased GSK-3β activity contributes to neuronal death and pathogenesis of ischemic stroke. Considering predominant roles of GSK-3β in neuronal apoptosis, modulation of this protein kinase is a reliable strategy for ischemic neuroprotection. In this review, we survey and synthesize the current knowledge about the role of GSK-3β in neuroprotection following the ischemic stroke.
Export Options
About this article
Cite this article as:
Hanumanthappa Pradeep, Densi Asha and Krishnamurthy Golgodu Rajanikant, Glycogen Synthase Kinase-β3 in Ischemic Neuronal Death, Current Neurovascular Research 2014; 11 (3) . https://dx.doi.org/10.2174/1567202611666140520151002
DOI https://dx.doi.org/10.2174/1567202611666140520151002 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Association of Dietary Prebiotic Consumption with Reduced Risk of
Alzheimer’s Disease in a Multiethnic Population
Current Alzheimer Research Fighting Type-2 Diabetes: Present and Future Perspectives
Current Medicinal Chemistry Is Erectile Dysfunction an Example of Abnormal Endothelial Function?
Current Vascular Pharmacology Clopidogrel in Secondary Ischemic Stroke Prevention
Recent Patents on Cardiovascular Drug Discovery The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design Chymase Inhibitors
Current Pharmaceutical Design Editorial (Thematic Issues: Pharmacological Mechanisms and Interventions in Ischemia/ Reperfusion-Induced Injury)
Current Pharmaceutical Design Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
Current Pharmaceutical Design Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris
Current Drug Safety Role of the RAS in Pancreatic Cancer
Current Cancer Drug Targets Angiogenetic Potential of Ad2/Hif-1α/Vp16 after Regional Application in a Preclinical Pig Model of Chronic Ischemia
Current Vascular Pharmacology The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
Mini-Reviews in Medicinal Chemistry Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors
Current Clinical Pharmacology Squalene as Novel Food Factor
Current Pharmaceutical Biotechnology Drugs Interfering with Apoptosis in Breast Cancer
Current Pharmaceutical Design The Bioartificial Kidney in the Treatment of Acute Kidney Injury
Current Drug Targets Targeting Dyslipidemia in the Metabolic Syndrome: An Update
Current Vascular Pharmacology Early Pathogenesis of Atherosclerosis: The Childhood Obesity
Current Pharmaceutical Design Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity
Current Medicinal Chemistry CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry